Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov;47(11):3501-6.
doi: 10.1128/JCM.01209-09. Epub 2009 Sep 16.

Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results

Affiliations

Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results

A Van Deun et al. J Clin Microbiol. 2009 Nov.

Abstract

The objectives of this study were to investigate the origin of highly discordant rifampin (rifampicin) (RMP) drug susceptibility test results obtained for Mycobacterium tuberculosis strains during proficiency testing. Nine Supra-National Tuberculosis Reference Laboratories tested the RMP susceptibilities of 19 selected M. tuberculosis strains, using standard culture-based methods. The strains were classified as definitely resistant (R) (n = 6) or susceptible (S) (n = 2) or probably resistant (PR) (n = 8) or susceptible (PS) (n = 3) based on rpoB mutations and treatment outcome. All methods yielded a susceptible result for the two S and three PS strains lacking an rpoB mutation and a resistant result for one R strain with a Ser531Leu mutation and one PR strain with a double mutation. Although the remaining 12 R and PR strains had rpoB mutations (four Asp516Tyr, three Leu511Pro, two Leu533Pro, one each His526Leu/Ser, and one Ile572Phe), they were all susceptible by the radiometric Bactec 460TB or Bactec 960 MGIT methods. In contrast, only one was susceptible by the proportion method on Löwenstein-Jensen medium and two on Middlebrook 7H10 agar. Low-level but probably clinically relevant RMP resistance linked to specific rpoB mutations is easily missed by standard growth-based methods, particularly the automated broth-based systems. Further studies are required to confirm these findings, to determine the frequency of these low-level-resistant isolates, and to identify technical improvements that may identify such strains.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Average results of RMP susceptibility tests by method and strain. The ratio of the MIC to the critical concentration is shown, with resistance defined as a ratio of >1. LJ, LJ medium; Radiometric, Bactec 460 radiometric method; MGIT, Bactec 960 MGIT system; R1 to R6, PR1 to PR8, PS1 to PS3, S1, and S2, individual strain codes, based on the presumptive RMP resistance classification.
FIG. 2.
FIG. 2.
RMP MIC ratios by the proportion method on LJ medium, read after 6 weeks of incubation, by SRL and strain. The ratio of the MIC to the critical concentration is shown, with resistance defined as a ratio of >1. LJ 6W, LJ medium, read after 6 weeks of incubation; R1 to R6, PR1 to PR8, PS1 to PS3, S1, and S2, individual strain codes, based on the presumptive RMP resistance classification.
FIG. 3.
FIG. 3.
RMP MIC ratios with the agar proportion and Bactec radiometric or Bactec MGIT method, by SRL and strain. The ratio of the MIC to the critical concentration is shown, with resistance defined as a ratio of >1. Radiometric, Bactec 460 radiometric method; MGIT, Bactec 960 MGIT system; R1 to R6, PR1 to PR8, PS1 to PS3, S1, and S2, individual strain codes, based on the presumptive RMP resistance classification.

References

    1. Barnard, M., H. Albert, G. Coetzee, R. O'Brien, and M. E. Bosman. 2008. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am. J. Respir. Crit. Care Med. 177:787-792. - PubMed
    1. Canetti, G., W. Fox, A. Khomenko, D. A. Mitchison, N. Rist, and N. A. Smelev. 1969. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull. W. H. O. 41:21-43. - PMC - PubMed
    1. Espinal, M. A., S. J. Kim, P. G. Suarez, K. M. Kam, A. G. Khomenko, G. B. Migliori, J. Baéz, A. Kochi, C. Dye, and M. C. Raviglione. 2000. Standard short-course chemotherapy for drug-resistant tuberculosis. Treatment outcomes in 6 countries. JAMA 283:2537-2545. - PubMed
    1. Gagneux, S., C. Davis Long, P. M. Small, T. Van, G. K. Schoolnik, and B. J. M. Bohannan. 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312:1944-1946. - PubMed
    1. Gillespie, S. H., O. J. Billington, A. Breathnach, and T. D. McHugh. 2002. Multiple drug-resistant Mycobacterium tuberculosis: evidence for changing fitness following passage through human hosts. Microb. Drug Resist. 8:273-279. - PubMed

MeSH terms